TY - JOUR
T1 - Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC
AU - Lim, Lillian
AU - Bui, Hung
AU - Farrelly, Olivia
AU - Yang, Jisheng
AU - Li, Li
AU - Enis, David
AU - Ma, Wanshu
AU - Chen, Mei
AU - Oliver, Guillermo
AU - Welsh, John D.
AU - Kahn, Mark L.
N1 - Funding Information:
This work was supported by National Institutes of Health, National Heart, Lung, and Blood Institute grants R01HL121650 and HL120846 (to M.L.K.), and by the Agency for Science, Technology and Research (Singapore) (L.L.).
Publisher Copyright:
© 2019 by The American Society of Hematology.
PY - 2019/11/14
Y1 - 2019/11/14
N2 - Hemostasis associated with tissue injury is followed by wound healing, a complex process by which damaged cellular material is removed and tissue repaired. Angiogenic responses are a central aspect of wound healing, including the growth of new lymphatic vessels by which immune cells, protein, and fluid are transported out of the wound area. The concept that hemostatic responses might be linked to wound healing responses is an old one, but demonstrating such a link in vivo and defining specific molecular mechanisms by which the 2 processes are connected has been difficult. In the present study, we demonstrate that the lymphangiogenic factors vascular endothelial growth factor C (VEGFC) and VEGFD are cleaved by thrombin and plasmin, serine proteases generated during hemostasis and wound healing. Using a new tail-wounding assay to test the relationship between clot formation and lymphangiogenesis in mice, we find that platelets accelerate lymphatic growth after injury in vivo. Genetic studies reveal that platelet enhancement of lymphatic growth after wounding is dependent on the release of VEGFC, but not VEGFD, a finding consistent with high expression of VEGFC in both platelets and avian thrombocytes. Analysis of lymphangiogenesis after fullthickness skin excision, a wound model that is not associated with significant clot formation, also revealed an essential role for VEGFC, but not VEGFD. These studies define a concrete molecular and cellular link between hemostasis and lymphangiogenesis during wound healing and reveal that VEGFC, the dominant lymphangiogenic factor during embryonic development, continues to play a dominant role in lymphatic growth in mature animals.
AB - Hemostasis associated with tissue injury is followed by wound healing, a complex process by which damaged cellular material is removed and tissue repaired. Angiogenic responses are a central aspect of wound healing, including the growth of new lymphatic vessels by which immune cells, protein, and fluid are transported out of the wound area. The concept that hemostatic responses might be linked to wound healing responses is an old one, but demonstrating such a link in vivo and defining specific molecular mechanisms by which the 2 processes are connected has been difficult. In the present study, we demonstrate that the lymphangiogenic factors vascular endothelial growth factor C (VEGFC) and VEGFD are cleaved by thrombin and plasmin, serine proteases generated during hemostasis and wound healing. Using a new tail-wounding assay to test the relationship between clot formation and lymphangiogenesis in mice, we find that platelets accelerate lymphatic growth after injury in vivo. Genetic studies reveal that platelet enhancement of lymphatic growth after wounding is dependent on the release of VEGFC, but not VEGFD, a finding consistent with high expression of VEGFC in both platelets and avian thrombocytes. Analysis of lymphangiogenesis after fullthickness skin excision, a wound model that is not associated with significant clot formation, also revealed an essential role for VEGFC, but not VEGFD. These studies define a concrete molecular and cellular link between hemostasis and lymphangiogenesis during wound healing and reveal that VEGFC, the dominant lymphangiogenic factor during embryonic development, continues to play a dominant role in lymphatic growth in mature animals.
UR - http://www.scopus.com/inward/record.url?scp=85075091423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075091423&partnerID=8YFLogxK
U2 - 10.1182/blood.2019001736
DO - 10.1182/blood.2019001736
M3 - Article
C2 - 31562136
AN - SCOPUS:85075091423
SN - 0006-4971
VL - 134
SP - 1764
EP - 1775
JO - Blood
JF - Blood
IS - 20
ER -